DKK3 and neoplasm: Overall, our results demonstrate that miR-582-3p activates Wnt signalling by targeting AXIN2, DKK3 and SFRP1; enhances stem cell-like traits; and leads to tumour recurrence and poor prognosis in NSCLC patients (Fig. 7d).